US EditionPublished • loading... • Updated
Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology
The collaboration combines Iktos's AI-driven molecular design with Pierre Fabre's oncology R&D, aiming to accelerate discovery of small-molecule cancer drugs with proven expertise.
Summary by Benzinga
6 Articles
6 Articles
Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology
CASTRES, France and PARIS, Jan. 9, 2026 /PRNewswire/ -- Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, today announced an integrated drug discovery collaboration to identify and develop novel small-molecule drug candidates in oncology. This initiative reflects both companies' commitment to advancing oncology research by integrating complementary strengths across computational …
·New York, United States
Read Full Article
Artificial intelligence is needed in French pharmaceutical research. The Pierre Fabre laboratories and the Iktos biotech have decided to join forces to discover molecules against cancer, thanks to the generative algorithms and robotic chemistry.
Coverage Details
Total News Sources6
Leaning Left0Leaning Right1Center3Last UpdatedBias Distribution75% Center
Bias Distribution
- 75% of the sources are Center
75% Center
C 75%
R 25%
Factuality
To view factuality data please Upgrade to Premium
